News
The intervention under investigation is GEN1056, a biological treatment administered via intravenous infusion. Its primary purpose is to evaluate safety and antitumor activity, with the ultimate goal ...
Though some individual reports have led to outsized moves. US-listed shares of the German drugmaker BioNTech (BNTX) rose ...
Warning comes after HHS Secretary Robert F. Kennedy Jr. announced cuts of nearly $500m in funding for mRNA vaccine projects, ...
Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA ...
Modern science emerged precisely to deal with the way everything can be manipulated – and scepticism over ‘facts’ goes all ...
Federal vaccine policy changes under RFK Jr. have some concerned health insurance will not cover COVID shots. A bill in NY seeks to mandate coverage.
Cancer vaccines in development rely on mRNA technology under attack by RFK Jr. “I am concerned that this could bleed over," ...
Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...
Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.
Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in ...
This speeding up of the production process is one of the key reasons mRNA vaccines have "long been distrusted by vaccine ...
Neither UTMB nor Moderna has confirmed the nature of the project included in the announcement, or how much funding is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results